Prognostic significance of microRNA miR-24 in cancers: a meta-analysis

References

• Bu J, Li H, Li XY, et al. Prognostic role of microRNA-126 for survival in malignant tumors: a systematic review and meta-analysis. Dis Markers. 2015;2015:739469.
   PubMed Web of Science ®Google Scholar
• Dai SL, Zhou J, Pan C, et al. Prognostic value of microRNA-145 in patients with various cancers: a meta-analysis. Cancer Biomark. 2015;15:507–513.
   PubMed Web of Science ®Google Scholar
• Ding L, Ni J, Yang F, et al. Promising therapeutic role of miR-27b in tumor. Tumour Biol. 2017;39:1010428317691657.
   Google Scholar
• Chhabra R, Dubey R, Saini N. Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases. Mol Cancer. 2010;9:232.
   PubMed Web of Science ®Google Scholar
• Yin Y, Zhong J, Li SW, et al. TRIM11, a direct target of miR-24-3p, promotes cell proliferation and inhibits apoptosis in colon cancer. Oncotarget. 2016;7:86755–86765.
   PubMedGoogle Scholar
• Zhang MX, Zhang J, Zhang H, et al. miR-24-3p suppresses malignant behavior of lacrimal adenoid cystic carcinoma by targeting PRKCH to regulate p53/p21 pathway. PLoS One. 2016;11:e0158433.
   PubMed Web of Science ®Google Scholar
• Yan L, Ma J, Zhu Y, et al. miR-24-3p promotes cell migration and proliferation in lung cancer by targeting SOX7. J Cell Biochem. 2018;119:3989–3998.
   PubMed Web of Science ®Google Scholar
• Lal A, Kim HH, Abdelmohsen K, et al. p16(INK4a) translation suppressed by miR-24. PLoS One. 2008;3:e1864.
   PubMed Web of Science ®Google Scholar
• Zheng X, Li J, Peng C, et al. MicroRNA-24 induces cisplatin resistance by targeting PTEN in human tongue squamous cell carcinoma. Oral Oncol. 2015;51:998–1003.
   PubMed Web of Science ®Google Scholar
• Dong X, Liu Y. Expression and significance of miR-24 and miR-101 in patients with advanced gastric cancer. Oncol Lett. 2018;16:5769–5774.
   PubMed Web of Science ®Google Scholar
• Gao Y, Liu Y, Du L, et al. Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior. Med Onco l. 2015;32:362.
   PubMed Web of Science ®Google Scholar
• Organista-Nava J, Gómez-Gómez Y, Illades-Aguiar B, et al. High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia. Oncol Rep. 2015;33:1639–1649.
   PubMed Web of Science ®Google Scholar
• Kerimis D, Kontos CK, Christodoulou S, et al. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma. Clin Biochem. 2017;50:285–292.
   PubMed Web of Science ®Google Scholar
• Le HB, Zhu WY, Chen DD, et al. Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients. Med Oncol. 2012;29:3190–3197.
   PubMed Web of Science ®Google Scholar
• Liu YX, Long XD, Xi ZF, et al. MicroRNA-24 modulates aflatoxin B1-related hepatocellular carcinoma prognosis and tumorigenesis. Biomed Res Int. 2014;2014:482926.
   PubMed Web of Science ®Google Scholar
• Liu L, Pan J, Wang H, et al. von Willebrand factor rescued by miR-24 inhibition facilitates the proliferation and migration of osteosarcoma cells in vitro. Biosci Rep. 2018;38. DOI:10.1042/BSR20180372
   Web of Science ®Google Scholar
• Meng FL, Wang W, Jia WD. Diagnostic and prognostic significance of serum miR-24-3p in HBV-related hepatocellular carcinoma. Med Oncol. 2014;31:177.
   PubMed Web of Science ®Google Scholar
• Su B, Xu T, Bruce JP, et al. hsa-miR-24 suppresses metastasis in nasopharyngeal carcinoma by regulating the c-Myc/epithelial-mesenchymal transition axis. Oncol Rep. 2018;40:2536–2546.
   PubMed Web of Science ®Google Scholar
• Wu XD, Liu Z, Long J, et al. Knockdown of miR-24 suppresses the proliferation, migration and invasion of gastric cancer cells and predicts a poor prognosis in gastric cancer. Int J Clin Exp Med. 2017;10:2911–2917.
   Web of Science ®Google Scholar
• Yin JY, Tang Q, Qian W, et al. Increased expression of miR-24 is associated with acute myeloid leukemia with t(8;21). Int J Clin Exp Pathol. 2014;7:8032–8038.
   PubMedGoogle Scholar
• Zhao G, Liu L, Zhao T, et al. Upregulation of miR-24 promotes cell proliferation by targeting NAIF1 in non-small cell lung cancer. Tumour Biol. 2015;36:3693–3701.
   PubMedGoogle Scholar
• Zhao J, Hu C, Chi J, et al. miR-24 promotes the proliferation, migration and invasion in human tongue squamous cell carcinoma by targeting FBXW7. Oncol Rep. 2016;36:1143–1149.
   PubMed Web of Science ®Google Scholar
• Zhao J, Chi J, Gao M, et al. Loss of PTEN expression is associated with high microRNA 24 level and poor prognosis in patients with tongue squamous cell carcinoma. J Oral Maxillofac Surg. 2017;75:1449.e1-1449.e8.
   Web of Science ®Google Scholar
• Zhou N, Yan HL. MiR-24 promotes the proliferation and apoptosis of lung carcinoma via targeting MAPK7. Eur Rev Med Pharmacol Sci. 2018;22:6845–6852.
   PubMedGoogle Scholar
• Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–1101.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed.). 1997;315:629–634.
   PubMed Web of Science ®Google Scholar
• Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–463.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Ding J, Cao J, Chen Z; Ding J, Cao J, Chen Z, et al. The role of long intergenic noncoding RNA 00511 in malignant tumors: a meta-analysis, database validation and review. Bioengineered. 2020;11:812–823.
   PubMed Web of Science ®Google Scholar
• Zhang C, Ren X, Zhang W, et al. Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers. Bioengineered. 2020;11:1112–1123.
   PubMed Web of Science ®Google Scholar
• Ma X, Bai J, Xie G, et al. Prognostic significance of microRNA-101 in solid tumor: a meta-analysis. PLoS One. 2017;12:e0180173.
   PubMed Web of Science ®Google Scholar
• Du WW, Fang L, Li M, et al. MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling. J Cell Sci. 2013;126:1440–1453.
   PubMed Web of Science ®Google Scholar
• Roscigno G, Puoti I, Giordano I, et al. MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer. Oncotarget. 2017;8:19507–19521.
   PubMedGoogle Scholar
• Lin SC, Liu CJ, Lin JA, et al. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncol. 2010;46:204–208.
   PubMed Web of Science ®Google Scholar
• Yu G, Jia Z, Dou Z. miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD. Oncol Rep. 2017;37:1123–1131.
   PubMed Web of Science ®Google Scholar
• Dong X, Ding W, Ye J; Dong X, Ding W, Ye J,et al. MiR-24-3p enhances cell growth in hepatocellular carcinoma by targeting metallothionein 1M. Cell Biochem Funct. 2016;34:491–496.
   PubMed Web of Science ®Google Scholar
• Chen L, Luo L, Chen W, et al. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53. Biomed Pharmacother. 2016;84:1113–1118.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang A, Li Y, et al. MiR-24 regulates the proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4 signaling. Cancer Lett. 2013;329:174–180.
   PubMed Web of Science ®Google Scholar
• Liu R, Zhang H, Wang X, et al. The miR-24-Bim pathway promotes tumor growth and angiogenesis in pancreatic carcinoma. Oncotarget. 2015;6:43831–43842.
   PubMedGoogle Scholar
• Quan J, Liu S, Dai K, et al. MicroRNA-23a/24-2/27a as a potential diagnostic biomarker for cancer: a systematic review and meta-analysis. Mol Clin Oncol. 2018;8:159–169.
   PubMed Web of Science ®Google Scholar